How Does USP 800 Affect Urology Practices?

Content Summary

Two commonly used drugs in urology, Mitomycin and Gemcitabine, are included on the NIOSH list. As hazardous medications, USP 800 requires significant investment to safely compound and administer doses of these drugs. Edge Pharma developed a solution that solves this issue for hospitals, surgery centers, and urology clinics. Using this methodology, we are able to apply this technique to other hazardous medications as well.

Access this content

Choose an option below

Register to access this content

Your Work Email

Your Full Name

Your Company

Your Job Function

You might also be interested in

Common Questions About Pharma-Grade Shell and Tube Heat Exchangers

When it comes to pharmaceutical manufacturing, the integrity of equipment is vital. Among the critical components in this industry are shell and tube heat exchangers....

A Comprehensive Approach for Solid Form Selection in Preclinical Development and Beyond.

Different solid forms (polymorphs, salts, cocrystals) of an active pharmaceutical ingredient (API) can have very different physico-chemical properties. Those differences can...

High-Throughput Sterile Filtration of Highly Viscous Pharmaceutical Formulations

In this work, high-pressure sterile filtration (HPSF) is presented as a method to increase yield without compromise on patient safety or product quality